Product Code: ETC071158 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Infectious disease biomarker testing involves the detection and analysis of specific biomolecules, such as antibodies or genetic material, to diagnose and monitor infectious diseases. This type of testing is essential in identifying pathogens and determining the appropriate treatment course for patients. In Saudi Arabia, the infectious disease biomarker testing market is driven by factors such as the prevalence of infectious diseases, advancements in diagnostic technologies, and increased healthcare spending.
The occurrence of infectious diseases, including respiratory infections, hepatitis, and sexually transmitted diseases, drives the demand for accurate and timely biomarker testing for early diagnosis and treatment. Ongoing advancements in biomarker testing technologies, such as polymerase chain reaction (PCR), immunoassays, and next-generation sequencing, enhance the sensitivity, specificity, and speed of infectious disease diagnosis. The Saudi Arabia government`s initiatives and healthcare programs to control and manage infectious diseases contribute to the growth of the biomarker testing market.
In certain regions of Saudi Arabia, limited access to healthcare services and diagnostic facilities may hinder early detection and treatment of infectious diseases. The cost of biomarker testing can be a barrier for some patients, and affordability may affect the adoption of advanced diagnostic technologies.
The Covid-19 pandemic has significantly impacted the global infectious disease testing market, including biomarker testing. In Saudi Arabia, the pandemic has led to an increased demand for Covid-19 testing, including biomarker testing, to manage the outbreak. While this surge in testing may have positively impacted the market, it also presented challenges in terms of scaling up testing capabilities and managing testing supplies.
Some key players in the Saudi Arabia infectious disease biomarker testing market include, Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and bioMerieux SA.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Saudi Arabia Infectious Disease Biomarker Testing Market Overview |
3.1 Saudi Arabia Country Macro Economic Indicators |
3.2 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Saudi Arabia Infectious Disease Biomarker Testing Market - Industry Life Cycle |
3.4 Saudi Arabia Infectious Disease Biomarker Testing Market - Porter's Five Forces |
3.5 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Saudi Arabia Infectious Disease Biomarker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Saudi Arabia Infectious Disease Biomarker Testing Market Trends |
6 Saudi Arabia Infectious Disease Biomarker Testing Market, By Types |
6.1 Saudi Arabia Infectious Disease Biomarker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By Product, 2018 - 2031F |
6.1.3 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2018 - 2031F |
6.1.4 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By Instruments, 2018 - 2031F |
6.1.5 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By Services and Software, 2018 - 2031F |
6.2 Saudi Arabia Infectious Disease Biomarker Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By Immunodiagnostics, 2018 - 2031F |
6.2.3 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By Clinical Microbiology, 2018 - 2031F |
6.2.4 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By PCR, 2018 - 2031F |
6.2.5 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By INAAT, 2018 - 2031F |
6.2.6 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2018 - 2031F |
6.2.7 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By Other Technologies, 2018 - 2031F |
6.3 Saudi Arabia Infectious Disease Biomarker Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By Physician Offices, 2018 - 2031F |
6.3.3 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By Reference Laboratories, 2018 - 2031F |
6.3.4 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By Hospitals, 2018 - 2031F |
6.3.5 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By Academic and Research Institutes, 2018 - 2031F |
6.3.6 Saudi Arabia Infectious Disease Biomarker Testing Market Revenues & Volume, By Others, 2018 - 2031F |
7 Saudi Arabia Infectious Disease Biomarker Testing Market Import-Export Trade Statistics |
7.1 Saudi Arabia Infectious Disease Biomarker Testing Market Export to Major Countries |
7.2 Saudi Arabia Infectious Disease Biomarker Testing Market Imports from Major Countries |
8 Saudi Arabia Infectious Disease Biomarker Testing Market Key Performance Indicators |
9 Saudi Arabia Infectious Disease Biomarker Testing Market - Opportunity Assessment |
9.1 Saudi Arabia Infectious Disease Biomarker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Saudi Arabia Infectious Disease Biomarker Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Saudi Arabia Infectious Disease Biomarker Testing Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Saudi Arabia Infectious Disease Biomarker Testing Market - Competitive Landscape |
10.1 Saudi Arabia Infectious Disease Biomarker Testing Market Revenue Share, By Companies, 2024 |
10.2 Saudi Arabia Infectious Disease Biomarker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |